These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 20807123)

  • 1. Clarification on drugs used to treat leishmaniasis.
    Papich MG
    J Am Vet Med Assoc; 2010 Sep; 237(5):493. PubMed ID: 20807123
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dog with leishmaniasis].
    Slappendel RJ
    Tijdschr Diergeneeskd; 2002 Jun; 127(11):360-1. PubMed ID: 12073781
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidelines for treatment of leishmaniasis in dogs.
    Oliva G; Roura X; Crotti A; Maroli M; Castagnaro M; Gradoni L; Lubas G; Paltrinieri S; Zatelli A; Zini E
    J Am Vet Med Assoc; 2010 Jun; 236(11):1192-8. PubMed ID: 20513197
    [No Abstract]   [Full Text] [Related]  

  • 4. [Leishmaniasis in a dog].
    Saar C
    Berl Munch Tierarztl Wochenschr; 1969 Sep; 82(18):354-5. PubMed ID: 5389963
    [No Abstract]   [Full Text] [Related]  

  • 5. Update on the diagnosis and management of Leishmania spp infections in dogs in the United States.
    Freeman K
    Top Companion Anim Med; 2010 Aug; 25(3):149-54. PubMed ID: 20937498
    [No Abstract]   [Full Text] [Related]  

  • 6. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
    Oliva G; Foglia Manzillo V; Pagano A
    Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canine leishmaniasis chemotherapy: dog's clinical condition and risk of Leishmania transmission.
    João A; Pereira MA; Cortes S; Santos-Gomes GM
    J Vet Med A Physiol Pathol Clin Med; 2006 Dec; 53(10):540-5. PubMed ID: 17105576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy in the treatment and control of leishmaniasis.
    Alvar J; Croft S; Olliaro P
    Adv Parasitol; 2006; 61():223-74. PubMed ID: 16735166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Leishmaniasis in dogs in Germany: epidemiological case analysis and alternatives to conventional causal therapy].
    Gothe R; Nolte I; Kraft W
    Tierarztl Prax; 1997 Jan; 25(1):68-73. PubMed ID: 9157633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraparesis caused by vertebral canal leishmaniotic granuloma in a dog.
    Cauduro A; Favole P; Lorenzo V; Simonetto L; Barda B; Cantile C; Asperio RM
    J Vet Intern Med; 2011; 25(2):398-9. PubMed ID: 21281352
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of meglumine antimoniate in canine leishmaniasis.
    Lamothe J
    Vet Rec; 2004 Mar; 154(12):378. PubMed ID: 15074332
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse urinary effects of allopurinol in dogs with leishmaniasis.
    Torres M; Pastor J; Roura X; Tabar MD; Espada Y; Font A; Balasch J; Planellas M
    J Small Anim Pract; 2016 Jun; 57(6):299-304. PubMed ID: 27112522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Canine leishmaniasis in Spain: data for the clinician].
    Ferrer L
    Enferm Infecc Microbiol Clin; 1989; 7(6):293-5. PubMed ID: 2490443
    [No Abstract]   [Full Text] [Related]  

  • 14. Polyarthritis associated with visceral leishmaniasis in a juvenile dog.
    Santos M; Marcos R; Assunção M; Matos AJ
    Vet Parasitol; 2006 Nov; 141(3-4):340-4. PubMed ID: 16824686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol.
    Manna L; Reale S; Vitale F; Picillo E; Pavone LM; Gravino AE
    Vet J; 2008 Aug; 177(2):279-82. PubMed ID: 17553711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral leishmaniasis and disseminated intravascular coagulation in a dog.
    Font A; Gines C; Closa JM; Mascort J
    J Am Vet Med Assoc; 1994 Apr; 204(7):1043-4. PubMed ID: 8045804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
    Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
    Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis.
    Meyerhoff A
    Clin Infect Dis; 1999 Jan; 28(1):42-8; discussion 49-51. PubMed ID: 10028069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prothidium and isometamidium as drugs against Trypanosomia brucei in dogs].
    Toure SM
    Rev Elev Med Vet Pays Trop; 1970; 23(3):321-6. PubMed ID: 5534036
    [No Abstract]   [Full Text] [Related]  

  • 20. Rational approaches for drug designing against leishmaniasis.
    Shukla AK; Singh BK; Patra S; Dubey VK
    Appl Biochem Biotechnol; 2010 Apr; 160(8):2208-18. PubMed ID: 19756413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.